fda pulls tirzepatide 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these Oral Tirzepatide Pill: FDA-Approved Options

PMID 2694231

The retatrutide versus semaglutide comparison and the broader landscape of tirzepatide alternatives provide context for evaluating which medication best suits individual needs

There are currently no FDA-approved drug therapies for MASH, and the disease is characterized by excess fat accumulation and inflammation in the liver, which leads to liver scarring or fibrosis

In clinical trials investigating retatrutide, a dose-escalation approach has been used to minimise gastrointestinal side effects and improve tolerability

The FDA does not review it for safety, quality, or whether it works, and it is not the same product as Mounjaro or Zepbound